0001209191-19-017304.txt : 20190306
0001209191-19-017304.hdr.sgml : 20190306
20190306160730
ACCESSION NUMBER: 0001209191-19-017304
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wiley Matthew T.
CENTRAL INDEX KEY: 0001759703
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36621
FILM NUMBER: 19662589
MAIL ADDRESS:
STREET 1: C/O FOAMIX PHARMACEUTICALS LTD.
STREET 2: 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 7670402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd.
CENTRAL INDEX KEY: 0001606645
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
BUSINESS PHONE: 97289316233
MAIL ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
FORMER COMPANY:
FORMER CONFORMED NAME: Foamix Ltd.
DATE OF NAME CHANGE: 20140428
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-05
0
0001606645
Foamix Pharmaceuticals Ltd.
FOMX
0001759703
Wiley Matthew T.
C/O FOAMIX PHARMACEUTICALS LTD.
2 HOLZMAN STREET
REHOVOT
L3
7670402
ISRAEL
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2019-03-05
4
P
0
13440
3.76
A
63440
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.725 to $3.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
/s/ Mutya Harsch as attorney-in-fact for Matthew Wiley
2019-03-06